One of the many aggressive and destructive forms of cancer is neuroendocrine carcinoma of colon. The worst part of this disease is that more often than not it is detected at the advanced stages where is it very difficult to do anything about it.
As the effects of neuroendocrine colon cancer become visible only at very advanced stages, the chances of survival of the patient drops drastically The tumors are mostly detected with distant metastases. In several surveys, reports reveal that in almost all cases of neuroendocrine cancer result in death.
Though the possibilities of neuroendocrine carcinoma in colon are very rare, if one has the misfortune to become affected the patient’s heath appears even worse than patients suffering from adenocarcinoma.
Researches have showcased that the end results of this cancer do not differ with age, sex or tumor location. However, neuroendocrine colon carcinoma does depend on the stage of the tumor. Normal trends reveal that most peopleshow that generally people in stage 1 and 2 of cancer usually do not suffer from neuroendocrine colon cancer. Though in several cases, when the tumor is in stage 3 or 4, it is a laborious and and difficult task the neuroendocrine colon carcinoma.
It is unfortunate that medical science has developed no adequate methods to deal with this particular cancer. One of the most popular methods that the doctors often use is immunohistochemical staining methods. this method assists the doctors to detect the severity of the neuroendocrine colon cancer and assists doctors in deciding on the most helpful medication and a way to treat it. Immunohistochemical staining methods is specifically used for neuroendocrine markers. Involved in that, is the staining of the tumor with a monoclonal antibody A-80 which helps to identify the quantum of neuroendocrine differentiation and nature of the damage on the patient’s health.
Neuroendocrine colon carcinoma is cumbersome to deal with and a case study where several patients suffered from this particular disease were extensively examined it was noted that the average survival rate surrounding this disease was approximately seven months. In a predominant stage the rates were as less as five months. The great majority of these cases were originally seen as carcinoids but they later developed in to neuroendocrine colon carcinoma. Neuroendocrine colon cancer has a poor prognosis and surgery is not always a perfect or even viable treatment so, even surgery does not provide the patient with a proper cure. Therefore it becomes necessary to make note of carcinoma on time and administer the proper treatment.